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The only therapeutic option which offers the potential of cure in primary or
secondary hepatic neoplasms is surgical resection. This is usually achieved by partial
resection although total resection and transplantation has been undertaken. Unfor-
tunately, the results of transplantation have been disappointing. Other surgical
measures are rarely employed. These include hepatic artery ligation, which has been
largely replaced by radiological embolisation with specific indications, and catheter
insertion into the hepatic artery or portal vein for the administration of cytotoxic
drugs. This too has given disappointing results.
Surgical resection of liver can be performed with low morbidity and mortality
today. Success is dependent on the expertise of the surgeon and the hepatologist.
Major liver resections should not be undertaken by the occasional hepatic resec-
tionist. Full diagnostic workup, including non-invasive and invasive investigations, is
required to provide both a diagnosis and a detailed anatomical route map before
surgery. Finally, success is dependent upon the selection of a suitable patient with a
favourable pathology. The patient’s general condition must be good to withstand
major hepatic surgery. Even limited hepatic resections of single localised lesions in
cirrhotic patients are only worthwhile if they have good liver functional reserve. The
Chiba group advocate that surgical resection be restricted to Child’s A grade
cirrhotic patients1. Tumour encapsulation in small lesions in cirrhotic patients
23 confers a significantly better prognosis ’. The fibrolamellar variant of hepatocellular
carcinoma should be sought out as a resection is associated with good prognosis.
There is debate whether pre-operative tru-cut needle biopsy should be performed.
Most internists believe it to be safe. This is true for deep seated lesions but the author
believes that superficial lesions abutting on the surface of the liver should not be
biopsied pre-operatively because the biopsy site leaves a weak spot in Glisson’s
capsule which may exude tumour during manipulation at the time of hepatic
resection. Needle tract recurrences have not been a problem other than in some
patients after hepatic transplantation.
ANATOMICAL CONCEPTS AND TYPES OF HEPATIC RESECTION
Modern anatomical concepts are based on earlier American4’5 and French6’7 studies.
Figure 1 shows the French concept which divides the liver into right and left livers
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Figure 1 Segmental anatomy of the liver as described by French workers. The eight segments are
depicted. The principal plane divides the liver into right and left livers6’7.
based on inflow vascular anatomy, and eight segments based on a combination of
inflow vascular and outflow hepatic venous anatomy. Although liver resections
have become standardised, terminology is confused because of semantic arguments
between the French and the American based groups. Table 1 compares French
and American terminology for the main major hepatic resections. Table 2 outlines
the four accepted major resections, and the three "lesser" resections. These
are depicted pictorially in Figures 2 and 3. Finally definite removal of extensive
liver tumours involving both lobes can be achieved by total resection and
transplantation.
Table 1 Terminology of major liver resections" semantic dispute.
French American
Right hepatectomy
Left hepatectomy
Right lobectomy
Left lobectomy
Right hepatic lobectomy
Left hepatic lobectomy
[Extended right hepatic lobectomy
[Right trisegmentectomy
Left lateral segmentectomySURGERY OF LIVER TUMOURS 175
Table 2 Types of liver resection.
Ma]or resections "Lesser" resections
[Right hepatic lobectomy Wedge resection
[Right hepatectomy
[Left hepatic lobectomy
[Left hepatectomy
[Extended right hepatic lobectomy
[Right lobectomy
[Left lateral segmentectomy
[Left lobectomy
Subsegmental resection
Segmental resection
Total resection
Transplantation
Figure 2 Major liver resections. A. Right hepatic lobectomy (right hepatectomy). B. Left hepatic
lobectomy (left hepatectomy). C. Extended right hepatic lobectomy (right lobectomy). D. Left lateral
segmentectomy (left lobectomy).
TECHNICAL CONSIDERATIONS
Most major hepatic resections can be performed through a bilateral subcostal
incision with or without a vertical extension to the xiphisternum or into the lower
mediastinum via a lower median sternotomy (Figure 4). The original extensions
into the right chest 8 are virtually never required. At an early stage the lobe to be
resected is freed by dividing the triangular ligament and then mobilised into the
wound.176 J. TERBLANCHE
Figure 3 "Lesser" liver resections. A. Wedge resection. B. Subsegmental resection. C. Segmental
resection.
Major resections are performed either by initially ligating the inflow vessel with
or without ligation of the relevant hepatic vein, prior to resection or by resection
with division of the inflow vessels within the liver parenchyma. In the author’s view
resection has been considerably simplified by the use of inflow occlusion clamping
the porta hepatis (Pringle manouevre) recognising that hepatic tissue withstands
9 10 normothermic ischaemia better than was previously believed’ Technically liver
tissue is divided by the finger fracture technique
11 or with the use of a blunt clamp.
Newer technical devices include suction dessicators, ultrasound and laser12. The
author has continued to use the simple finger fracture or instrument fracture
techniques to divide liver parenchyma.
Several lessons learnt from the trauma experience have helped to improve the
technical aspects of liver surgery. Peri-hepatic packing has proved extremely
13 15 beneficial in our experience of trauma management Bleeding from the liver
surface can be controlled. The technique has been applied to resections for liver
tumours, if bleeding is excessive, to allow the anaesthetist time to resuscitate the
patient prior to continuing the operation. It has also proved beneficial in patients
who develop a coagulopathy due to major bleeding. Here the packs may be left
in situ for 24 to 48 hours. Inflow vascular occlusion, occluding the porta hepatis
using the Pringle maneouvre as described in 190816, is valuable in trauma manage-
ment17’18 and has been adopted routinely by our group for liver resection operations
in recent years. It has also been used by others and has significantly simplified
the procedure of liver resection in both normal and cirrhotic livers. 19. Blood
loss is markedly reduced. Like others we frequently employ inflow occlusionSURGERY OF LIVER TUMOURS 177
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Figure 4 Incisions to provide exposure for liver resections. Bilateral subcostal incision with or without
"Mercedes" extension to xiphisternum. Extension into the lower mediastinum may be required but
extension into the right chest is very rarely used.
for between 30 and 60 minutes during liver resection procedures and have not
noted untoward effects. If major bleeding occurs involving the hepatic veins or
vena cava during the resection procedure the liver can be completely isolated by
a combination of the Pringle manoeuvre and occlusion of the vena cava above and
below the liver2’21. This technique is used for major hepatic vein and vena cava
injuries and has proved lifesaving in the occasional patient with a large and techni-
cally difficult to remove liver tumour.
PRIMARY MALIGNANT TUMOURS
Recommendations on the resectability of primary malignant tumours of the liver
and the anticipated five year survival rate are presented in Table 3. Single or
isolated lesions in non-cirrhotic livers should be resected. Here formal lobectomy
or liver resection is usually recommended. Operative mortality should approach
zero in expert hands8’2225. The five year survival rate should be between 20 and
40%, if the selection criteria referred to earlier are adhered to. The recently
recognised fibrolamellar variant of primary hepatocellular carcinoma must be178 J. TERBLANCHE
Table 3 Resection for primary malignant liver tumours.
Pathological type Resect 5 Year survival%
Hepatocellular Carcinoma
No cirrhosis" Single Yes 20-40
Fibrolamellar Yes + 50
Multicentric No Nil
Cirrhosis: Small ("Minimal" HCC) Yes + 50
Mild cirrhosis: Good LF Yes Q
Severe cirrhosis: Large No Nil
Cholangiocarcinoma Yes Few
Other Yes Few
aLF: Liver functional
identified, as the results of resection, even for large tumours, are much more
favourable. Thus resection should be attempted whenever possible26’27. For the
many patients who present with multicentric lesions or with lesions involving both
lobes of the liver or with distant metastases, surgery is contra-indicated and five
year survival does not occur.
In the past, particularly in the West, patients with cirrhotic livers who presented
with primary hepatocellular carcinoma were not considered for surgery because of
the high mortality associated with major resection. This still applies to patients
with severe cirrhosis and large lesions, or in patients with decompensated liver
disease even if they have a small hepatocellular carcinoma1. On the other hand
patients with mild cirrhosis and good liver function have been demonstrated to
withstand liver resection with a reasonable chance of survival although the figures
are difficult to find28.
Recent attention has been focused on the value of diagnosing hepatocellular
3 19,20 23-.28 30 carcinoma in cirrhotic patients at an early stage using screening Alpha
fetoprotein and ultrasound have been used in high risk population groups, such as
patients positive for hepatitis B surface antigen. Good results with local subseg-
mental or segmental resections1’3’19’2’23’28’29 have been reported, particularly from
the East, but also more recently from Europe. Such patients, particularly those
reported from the East, have a five year survival rate in some reports of over 50%.
It has been noted that the prognosis is particularly favourable when the lesion is
2 29-.30 small and has a well defined capsule’ Unfortunately early reports from the
West indicate that the percentage of patients with favourable encapsulated lesions
is much less than in the East. Our experience in Cape Town in black patients has
also been unfavourable, although others have identified some favourable patients.
A recent study from Italy has identified a number of patients with encapsulated
lesions who have done well post-operatively3. Kanematsu has pointed out that
limited hepatic resection (subsegmental resection) can be performed in patients
with moderately compromised liver function with results similar to those achieved
by formal resection in fit patients3. Ohnishi et al. have assessed the results ofSURGERY OF LIVER TUMOURS 179
various forms of management in patients divided into Child’s A, B and C risk
categories and concluded that surgery should only be recommended in patients
with cirrhosis and minimal hepatocellular carcinoma who are Child’s grade A
whereas no therapy at all, not even embolisation, is advocated for patients who
are Child’s grade C1. Although we have no experience of its use, there is convincing
evidence in the literature that intra-operative ultrasound is of assistance, both in
isolating deep seated lesions and in planning the extent of resection31.
There is dispute whether the subsegmental resections advocated by our group
are as satisfactory as formal segmental resections. We remain unconvinced that
there is a need for formal segmental resections for minimal hepatocellular
carcinoma. It must be remembered that the natural history of these early tumours
(the so called "minimal" hepatocellular carcinomas) has not been clearly defined.
We are not even certain whether the prognosis would be good if the tumours
remain unresected32. Nevertheless there is increasing data to support a policy of
resection in cirrhotic patients particularly those who are otherwise fit and have only
moderately deranged liver function.
Cholangiocarcinoma should be resected when it presents as a mass in the liver
(peripheral cholangiocarcinoma), although the results have not been as encourag-
ing as with isolated hepatocellular carcinoma. The treatment of central cholan-
giocarcinoma or cholangiocarcinoma presenting at the main hepatic duct junction
remains an area of considerable controversy. Our group has recently updated
previous data on the use of the U-tube for palliative therapy (with or without
radiotherapy) in these patients and pointed out that survival is no worse than in
the large selected series of patients undergoing major hepatic resections along with
resection of the cholangiocarcinoma33. Others dispute this view and advocate a
more radical surgical approach34’35.
The unusual varieties of neoplasms occurring in children should be resected as
some can be potentially cured with the addition of chemotherapy. 36. Some of the
other rare lesions, including cystadenocarcinoma, are worth resecting but anglo-
sarcoma has proved incurable.
SECONDARY MALIGNANT NEOPLASMS OF THE LIVER
With the exception of some childhood tumours, secondary metastatic disease
of the liver from a colorectal primary or from a neuro-endocrine primary are the
only major groups that should be considered for hepatic resection (Table 4).
Table 4 Resection for secondary malignant liver tumours.
Pathological type (Primary) Resect 5 Year survival (%)
Colorectal
Single (localised) Yes +20 (15-40)
Diffuse No Nil
Neuro-Endocrine Q Q
Other No No
Carcinoma arising in the remainder of the gastrointestinal tract with associated
haematogenous or local spread into the liver is usually incurable and hepatic180 J. TERBLANCHE
resection is seldom indicated37. Unfortunately the majority of patients who present
with metastatic disease in the liver arising from a colorectal primary have diffuse
metastates. Resection is not indicated and five year survival does not occur. On
the other hand patients presenting with a single or a localised metastasis in the
liver from a colorectal primary should be actively sought out and treated by hepatic
resection38-48. There is a dispute whether formal hepatic resection of a major lobe
or liver segment is required or whether subsegmental resection is adequate.
For single lesions five year survival rates of between 15 and 40% are reported
and one can anticipate at least a 20% five year survival rate in a patient who has
had a suitable lesion resected under favourable circumstances. A major multicentre
review has provided guidelines for resection and indicated which patients should
not be considered for resection. Results are bad if patients have positive hepatic
nodes or extra-hepatic metastases, even if these are resectable. Results have also
been poor in patients with four or more metastases in the liver47. A recent review
from New York, based on Fortner’s personal experience, arrived at the following
conclusion: "... the archaic and primitive method of surgical excision of cancer
remains, regretfully, the most effective treatment of localised metastatic colorectal
cancer in the liver... Current knowledge has made such treatment possible, safe,
,39 and effective Unfortunately only a very few patients with colorectal secondary
38 hepatic metastases are suitable for resection Adjuvant chemotherapy has had no
demostrable effect on survival patterns in most reviews43. In the multi-institutional
survey of Hughes et al. the overall five year survival was 33% and disease free
survival 2t% using actuarial analysis47. Individual series reported by experts with
a specific referral practice have reported five year survival rates in patients who
undergo resection for cure of approaching 50% 39
Patients with neuro-endocrine tumours with metastases to the liver should be
treated by hepatic resection, if the primary is controlled and if the tumour can be
removed. In some instances in symptomatic patients with hormonal symptoms
debulking has proved effective. In our view resection is preferable to radiological
arterial embolisation if it can be undertaken with a low morbidity and mortality.
Nevertheless radiological embolisation has provided good symptomatic relief in a
number of patients49’.
BENIGN LIVER TUMOURS
Benign liver tumours are rare. The most common benign lesion is a haemangioma
and the only solid benign liver tumours occuring with any frequency are focal
nodular hyperplasia and hepatic adenoma. Knowledge of benign tumours is
important for two reasons. Firstly many of the lesions are small and may be found
incidentally at surgery. Here there is a danger, especially in operations for intra-
abdominal malignancy, that the lesions may be mistaken for metastases and either
inappropriately treated or an incorrect prognosis given to the patient. The second
is the interest in the possible association with the use of oral contraceptive pills.
This applies particularly to hepatic adenoma but also to focal nodular hyperplasia.
Haemangiomas are relatively common with a reported autopsy incidence varying
between 0.4 and 7.30/0 51 but this may be an overestimate. The majority are small
and asymptomatic and require no therapy other than the recognition of the
diagnosis in patients with intra-abdominal malignancy. The risk of haemorrhageSURGERY OF LIVER TUMOURS 181
has been over emphasised and is very uncommon52. We believe that small lesions
should be left untreated and that even large lesions should not be treated by hepatic
resection unless they are symptomatic. We have published a small series of large
symptomatic hepatic haemangiomas that have responded well to formal hepatic
resections53.
The issue of resection for hepatic adenoma and focal nodular hyperplasia
remains controversial, particularly when they are associated with the use of the
contraceptive pill. We believe the diagnosis can be made on imaging and needle
biopsy. The patient should have the contraceptive pill stopped and another form
of contraception introduced. They should be re-evaluated at 3 to 6 months inter-
vals54. Others have advocated resection5, particularly for hepatic adenoma because
of the danger of spontaneous rupture and intraperitoneal haemorrhage56. Spon-
taneous resolution of both hepatic adenoma and focal nodular hyperplasia have
been reported after stopping the contraceptive pill54’57. Both of these lesions also
occur in patients not taking the contraceptive pill and focal nodular hyperplasia
also occurs in males. Under these circumstances resection should only be
performed when required for diagnosis. This is rare as the lesion is usually
diagnosed on non-invasive imaging and by ultrasound guided needle biopsy when
deep seated. Small superficial lesions can be resected safely as a wedge resection,
or occasionally by a subsegmental resection, when required for diagnosis.
LIVER TRANSPLANTATION FOR2 LIVER TUMOURS
There has been considerable dispute about the role of liver transplantation in liver
tumour patients58-6. Patients with unresectable fibrolamellar variant of hepato-
cellular carcinoma should be considered for transplantation, as reasonable results
have been reported, particularly from Starzl’s group26. There may be a place for
transplanting patients with microscopic low grade hepatocellular carcinoma but we
do not believe that transplantation is justified in patients with high grade malignant
hepatocellular carcinomas because of the very poor outcome. Both Pichlmayr from
Germany and Bismuth from France believe transplantation is justified, because of
the occasional satisfactory palliation achieved, even if long term survival is not
anticipated8. Patients with both central and peripheral cholangiocarcinoma have
been transplanted but the results have been dismal. We continue to advocate
palliative intubation with the U-tube, with or without radiotherapy, for patients
33 61 presenting with hilar cholangiocarcinoma
CONCLUSION
Liver resection offers the only hope of cure in patients with either primary or
secondary malignant liver neoplasms. Major hepatic resection in patients with
normal liver function and without cirrhosis is possible with a near zero mortality
if undertaken by an experienced surgeon in a major centre. Patients with single or
isolated primary hepatocellular carcinoma or secondary colorectal metastases to
the liver should be actively sought out and treated by resection. There is increasing
evidence that cirrhotic patients with reasonable hepatic reserve and who present
with small ("minimal") hepatocellular carcinomas should be detected by screening182 J. TERBLANCHE
in high risk populations and offered surgery. Peripherally placed cholangiocar-
cinomas should probably be resected although the results of treatment have not been
as satisfactory as with hepatocellular carcinoma. Central and hilar cholangiocar-
cinoma management remains controversial. Patients with neuro-endocrine secon-
daries frequently require resection. Benign liver tumours should only be resected if
symptomatic, or if small and superficial, to confirm the benign diagnosis.
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